• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 929

2′-fucosyllactose

Intended Use: Intended for use as an ingredient in exempt infant formula for pre-term infants; exempt hypoallergenic infant formula for term infants; and hypoallergenic toddler formula at a level of 2 g/L of formula, as consumed.
Basis: Scientific procedures
Notifier: Jennewein Biotechnologie GmbH
Notifier Address: Maarweg 32
D-53619 Reinbreitbach
GERMANY
GRAS Notice (releasable information): GRN 929 (in PDF) (4.2 MB)
FDA's Letter: Pending

2362  

-
-